Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study.
Holger ReineckeSabine JürgensmeyerChristiane M EngelbertzJoachim GerssPaulus F KirchhofGünter BreithardtRupert BauersachsChristoph WannerPublished in: BMJ open (2018)
NCT02933697,Pre-results.